The Procter & Gamble Company (NYSE:PG) Shares Bought by Cypress Wealth Services LLC

Cypress Wealth Services LLC increased its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 6.6% during the third quarter, HoldingsChannel.com reports. The fund owned 2,885 shares of the company’s stock after buying an additional 178 shares during the period. Cypress Wealth Services LLC’s holdings in Procter & Gamble were worth $500,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble during the 2nd quarter worth approximately $28,000. Fairway Wealth LLC purchased a new position in shares of Procter & Gamble during the second quarter valued at $29,000. Transcendent Capital Group LLC acquired a new position in Procter & Gamble during the fourth quarter valued at $31,000. Ruedi Wealth Management Inc. lifted its stake in Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares in the last quarter. Finally, POM Investment Strategies LLC acquired a new stake in Procter & Gamble during the 2nd quarter worth about $34,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Procter & Gamble

In other news, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the transaction, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at $6,325,360. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 383,194 shares of company stock valued at $65,140,718 in the last ninety days. Company insiders own 0.17% of the company’s stock.

Procter & Gamble Stock Performance

Procter & Gamble stock traded down $0.39 on Thursday, reaching $168.88. 744,633 shares of the stock were exchanged, compared to its average volume of 6,652,701. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a twelve month low of $141.66 and a twelve month high of $177.94. The firm has a fifty day moving average price of $171.39 and a two-hundred day moving average price of $166.65. The stock has a market cap of $398.58 billion, a PE ratio of 27.66, a PEG ratio of 3.73 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.03. The business had revenue of $20.53 billion during the quarter, compared to analysts’ expectations of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm’s revenue was down .1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.37 EPS. Sell-side analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.38%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.69%.

Analysts Set New Price Targets

PG has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft upped their target price on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Piper Sandler assumed coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target on the stock. Citigroup increased their price objective on Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Finally, DA Davidson started coverage on Procter & Gamble in a research note on Wednesday. They issued a “neutral” rating and a $159.00 target price on the stock. Ten investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus price target of $175.05.

Get Our Latest Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.